Company news

AREV NanoTec Brands Inc news in 2021

AREV NanoTec Brands Inc's news releases, calls and decks from 2021, newest first.

View company

AREV Life Sciences appoints Allan Echino as Director and Denby Greenslade as interim CFO

December 23, 2021

AREV Life Sciences Settles Pending Litigation with Harvey

December 9, 2021

AREV Life Sciences / Absolem JV Receives Extraction Results

December 2, 2021

AREV Acquires Wright & Well Essentials Inc.

November 30, 2021

AREV Life Sciences Global Corp Announces Stock Option Grant

November 8, 2021

AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB REVISED RELEASE first issued July 28, 2021

September 7, 2021

AREV Announces Brian Cameron as Chief Financial Officer

September 2, 2021

CSE Bulletin: Name Change - AREV Nanotech Brands Inc. (AREV)

August 10, 2021

AREV Changes their name to AREV Life Sciences Global Corp.

August 9, 2021

AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB

July 29, 2021

Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN(TM), a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation

July 22, 2021

AREV Annual and Special General Meeting Results Appoints Mel Maxwell as an AREV Director

July 20, 2021

AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subisidary, AREV Life Sciences, Inc.

July 6, 2021

AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins for Use in Its Ready-To-Use Therapeutic Foods

June 16, 2021

AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock

June 10, 2021

Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs

June 3, 2021

AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board

June 2, 2021

AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs

June 1, 2021

AREV Nanotec Brands Inc. Announces Management Cease Trade Order Revoked

June 1, 2021

AREV Nanotec Brands Inc. Provides Management Cease Trade Order Update

May 14, 2021

Arev Nanotec Brands Inc. Filing Financial Statements for the Fiscal Year Ended December 31, 2020 After Due Date

May 4, 2021

ARev Announces Collaboration and Exclusivity Agreement with a Global Leader in Hemp-Derived Cannabinoid Development and Production

April 13, 2021

Arev Nanotec Brands Inc. Announces Closing of their Non-Brokered Private Placement

March 31, 2021

AREV Nanotec Joins BIOTECanada

March 2, 2021

AREV Nanotec Appoints Chad S. Johnson, Esq. as Special Counsel for Corporate Development

March 1, 2021

AREV Nanotec Announces Corporate Update via Zoom on March 12, 2021

February 25, 2021

AREV Nanotec Board of Directors Welcomes Kevin Phelps

February 24, 2021

AREV NanoTec joins BIO

February 23, 2021

AREV Cambodia Brands its Permaculture Project to Support International RUTF Market Launch

February 22, 2021

AREV Engages Dr. Jay Noller to Join the Advisory Board

February 19, 2021

AREV's Nanotech Initiates Early-Stage Antiviral Photochemistry Derivation Discovery Program for Pandemic Viral Pathogens

February 17, 2021

AREV Nanotechnology becomes a sponsor of the National Sciences Academy 2021 Hemp Symposium

February 10, 2021

AREV Appoints DR. Roscoe Moore to Join the Advisory Board

February 9, 2021

AREV Nanotec Corporate Update on Latest Innovation

February 4, 2021

AREV Engages Dr. Uma Dhanabalan to Join the Advisory Board

February 2, 2021

AREV NanoTec Mushroom Extraction Joint Venture Signs Robert Rogers, World Renowned Mycologist, Herbalist & Author of Over 50 Books on Plant Medicine

January 28, 2021

AREV NanoTec Completes Phase 1 of Mushroom Extraction Joint Venture with Absolem Health

January 26, 2021

AREV Nanotec Announces the Intention to Enter into an Operating Agreement

January 25, 2021

ARev NanoTec Brands Inc. Announces a Non-Brokered Private Placement

January 25, 2021

AREV Engages Dr. Robert Melamede as Scientific Product Champion

January 19, 2021

AREV Achieves High Capacity Nanotechnology Extraction

January 14, 2021

AREV NanoTec Engages QNR Associates to Advise on Filing Health Canada Product Applications and Closes Private Placement

January 6, 2021